CD Biosynsis offers specialized Corynebacterium glutamicum CRISPRi Gene Repression Services, providing a powerful tool for the tunable, reversible, and non-permanent fine-tuning of gene expression. CRISPR Interference (CRISPRi) uses a nuclease-deactivated Cas9 (dCas9) fused with a repressor domain to block transcription initiation, offering a superior alternative to permanent gene knockout. This service is essential for Metabolic Control Analysis (MCA), rapidly identifying rate-limiting steps, and optimizing pathway flux in C. glutamicum without altering the underlying genome sequence. We deliver optimized systems for highly efficient gene knockdown, enabling precise control over central metabolism and regulatory networks to accelerate your strain development and optimization projects.
Get a QuoteIn metabolic engineering, the precise downregulation of a gene is often more effective than complete inactivation (knockout), as it allows for optimal pathway balancing while maintaining cellular fitness. CRISPRi provides this capability by offering a tunable expression dial controlled by an inducer (e.g., anhydrotetracycline). This is particularly valuable in C. glutamicum for essential genes, where complete knockout is lethal, and for rapidly investigating the phenotypic consequences of a range of expression levels. Our proprietary CRISPRi platform ensures robust, tightly regulated repression tailored for the specific genome and regulatory environment of C. glutamicum.
Identifying Rate-Limiting Steps
Systematic, transient repression of different pathway genes to rapidly identify the Metabolic Control Analysis (MCA) coefficients and true bottlenecks in the flux.
Optimal Pathway Balancing
Fine-tuning the expression of key pathway enzymes to avoid the accumulation of toxic intermediates and achieve the optimal stoichiometric ratio for maximum yield.
Downregulating Competing Pathways
Reversible repression of byproduct formation genes, allowing for easy comparison of various flux redirection levels without permanent genomic alteration.
Essential Gene Study
Allows for the controlled partial knockdown of essential genes to study their function and dosage requirements without causing cell death.
Rapid Phenotype Screening
Quickly correlating gene repression levels with phenotypic changes (e.g., growth, titer) across a library of targets using a single induction agent.
dCas9 Expression Cassette
Stable chromosomal integration or plasmid-based expression of the deactivated Cas9 (dCas9) under a tight, inducible promoter.
Optimized sgRNA Design
Targeting the non-template strand near the Transcription Start Site (TSS) for maximum transcriptional interference and repression strength.
Our process focuses on delivering a robust system with quantifiable, tunable repression levels.
1. dCas9 Host Construction
2. sgRNA Design & Repression Vector
3. Transformation & Tuning
4. Repression Level Verification (QC)
Stable integration of the dCas9 expression cassette into the C. glutamicum host chromosome under an inducible promoter.
Verification of dCas9 basal and induced expression levels (Western Blot).
Bioinformatic design of specific sgRNAs targeting the promoter region of the gene(s) of interest.
Construction of the sgRNA expression plasmid or chromosomal integration cassette.
Introduction of the sgRNA vector into the dCas9 host.
System calibration: determining the optimal inducer concentration range for graded levels of repression.
Multiplexing: construction of sgRNA arrays for simultaneous repression of several genes.
Highly Tunable Repression
Repression level can be precisely adjusted via inducer concentration, offering fine metabolic control unmatched by permanent knockout.
Non-Permanent & Reversible
Gene function returns when the sgRNA/dCas9 expression stops, allowing for reversible studies and maintenance of the original genome integrity.
Multiplexing for Pathway Balancing
Simultaneous repression of multiple targets using sgRNA arrays, critical for optimizing the expression ratio within complex pathways.
Metabolic Control Analysis (MCA)
The tunable nature of CRISPRi is ideal for MCA, accurately determining the control coefficient of each enzyme in a pathway.
"The CRISPRi system provided perfect, graded repression of our target gene. The qRT-PCR results confirmed the expression level was precisely controllable by the inducer concentration."
Dr. Chen, Head of Strain Engineering, Industrial Amino Acid Producer
"Using CRISPRi, we quickly tested 10 different expression levels of a critical regulatory gene without ever having to make a permanent knockout. This saved us months of engineering time."
Mr. David Smith, Project Manager, Metabolic Pathway Optimization Group
"Their multiplex CRISPRi system was key to balancing the flux in our heterologous pathway. By simultaneously repressing two native competing genes, we achieved a new production optimum."
Dr. Lena Koo, R&D Scientist, Synthetic Biology Startup
"The final strain delivered was stable and the repression system was tightly regulated, showing minimal leakiness, which is crucial for our high-titer bioprocess."
Dr. Alan Rivas, Lab Director, Applied Microbiology Institute
What is the difference between CRISPRi and Gene Knockout?
Knockout is a permanent genomic deletion that causes complete inactivation. CRISPRi is a reversible, non-genomic intervention that causes partial, tunable repression of gene expression by blocking transcription initiation with dCas9.
How do you control the level of gene repression?
The level of repression is primarily controlled by varying the concentration of a chemical inducer (e.g., anhydrotetracycline) that regulates the expression of the dCas9 protein.
Can CRISPRi be used on essential genes in C. glutamicum?
Yes, this is a key advantage. Since CRISPRi allows for partial knockdown rather than total loss of function, it can be used to study the function and sensitivity of genes that are essential for cell viability.
How is the repression efficiency verified (QC)?
We verify repression efficiency by measuring the remaining mRNA levels using qRT-PCR and, if antibodies are available, the target protein level via Western Blot under various inducer concentrations.
Do you offer systems for multiplex gene repression?
Yes. We design sgRNA arrays that can simultaneously target multiple unlinked genes using a single dCas9 component, enabling the complex balancing of multi-enzyme pathways.
What is the typical range of repression achievable with your system?
Our optimized systems typically achieve repression levels ranging from a mild knockdown (e.g., 5-10% residual expression) up to near-complete transcriptional repression (e.g., >95% knockdown).
What are the final deliverables for a CRISPRi project?
You receive the engineered C. glutamicum host strain containing the dCas9 cassette, the sgRNA expression vector, the optimized induction protocol, and a comprehensive QC Report detailing repression efficiency.
Does the CRISPRi system integrate into the C. glutamicum chromosome?
We typically recommend stable chromosomal integration of the dCas9 cassette for maximum stability, although plasmid-based systems can be provided for rapid, transient expression studies.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.